New Submissions Are Not Currently Being Accepted
Samples sent after April 10, 2024 will be put on hold.
Viewing desktop version: Switch to Mobile
M30
Sold as: Oxyxodone Replica
ID: 11051
Test Date: Aug 24, 2021
Pub. Date: Aug 24, 2021
Src Location: Los Angeles, CA
Submitter Loc: Los Angeles, CA
United States
Color: Blue
Size: 108 mg, 6.53 mm x 3.26 mm
Data Source: DrugsData
Tested by: DDL
Lab's ID: 21080071
Sold as: Oxyxodone Replica
Expected to be: Cutting Agents, Binders, Fillers
Has Been Tried: Yes
Lab comments:
Regarding Metamizole / 4-Methylaminoantipyrine:
Our current GC/MS protocol can not distinguish between metamizole and 4-methylaminoantipyrine. 4-Methylaminoantipyrine is a metabolite of metamizole. Their mass spectra are indistinguishable because metamizole undergoes thermal decomposition to 4-methylaminoantipyrine and aminopyrine during GC-MS analysis. The chemical identified in this sample could be either Metamizole or 4-Methylaminoantipyrine, or a combination of the two.
Round light blue tablet with 'M' on one side, '30' and break line on the other. Counterfeit oxycodone.
A reminder that DrugsData is not allowed to provide quantitative results for samples it analyzes, because our lab is constrained by rules set by the US DEA. Inert diluents, fillers and binders can not be reported even if they might be present. This means 'purity' can't be confirmed, either, as described in the DrugsData FAQ.